A double-edged kinase lyn: A positive and negative regulator for antigen receptor-mediated signals

Journal of Experimental Medicine

Volumn 187, Issue 8, 1998, Pages 1343-1348

  Nishizumi, Hirofumi ^a   Horikawa, Keisuke ^a   Mlinaric Rascan, Irena ^a   Yamamoto, Tadashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CD22 ANTIGEN; FC RECEPTOR; GENE PRODUCT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN M; LYMPHOCYTE RECEPTOR; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL ACTIVATION; CROSS LINKING; IMMUNOPRECIPITATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SPLEEN CELL;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD22; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; B-LYMPHOCYTES; CELL ADHESION MOLECULES; GENE TARGETING; LECTINS; LYMPHOCYTE ACTIVATION; MICE; MICE, MUTANT STRAINS; MUTAGENESIS; PHOSPHORYLATION; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, IGG; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TYROSINE;

EID: 0032550365     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.8.1343     Document Type: Article

References (38)

1. Burkhardt, A.L., M. Brunswick, J.B. Bolen, and J.J. Mond. 1991. Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein kinases. Proc. Natl. Acad. Sci. USA. 88:7410-7414.
2. Yamanashi, Y., T. Kakiuchi, J. Mizuguchi, T. Yamamoto, and K. Toyoshima. 1991. Association of B cell antigen receptor with protein tyrosine kinase Lyn. Science. 251:192-194.
3. Eisenman, E., and J.B. Bolen. 1992. Engagement of the high-affinity IgE receptor activates src-protein-related tyrosine kinases. Nature. 355:78-80.
4. Kurosaki, T., M. Takata, Y. Yamanashi, T. Inazu, T. Taniguchi, T. Yamamoto, and H. Yamamura. 1994. Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling. J. Exp. Med. 179:1725-1729.
5. Lyn and a 120-kDa phosphoprotein. Proc. Natl. Acad. Sci. USA. 92:359-363.
6. Yamanashi, Y., M. Okada, T. Semba, T. Yamori, H. Umemori, S. Tsunasawa, K. Toyoshima, D. Kitamura, T. Watanabe, and T. Yamamoto. 1993. Identification of HS1 protein as a major substrate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling. Proc. Natl. Acad. Sci. USA. 90:3631-3635.
7. Yamanashi, Y., T. Fukuda, H. Nishizumi, T. Inazu, K. Higashi, D. Kitamura, T. Ishida, H. Yamamura, T. Watanabe, and T. Yamamoto. 1997. Role of tyrosine phosphorylation of HS1 in B cell antigen receptor-mediated apoptosis. J. Exp. Med. 185:1387-1392.
8. lyn, in the B cell antigen receptor-mediated signaling. J. Exp. Med. 183:675-680.
9. Wang, J., T. Koizumi, and T. Watanabe. 1996. Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice. J. Exp. Med. 184:831-838.
10. Chan, V.W., F. Meng, P. Soriano, A.L. DeFranco, and C.A. Lowell. 1997. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signaling initiation and down-regulation. Immunity. 7:69-81.
11. Nathanson, S.D., P.L. Zamfirescu, S.I. Drew, and S. Wilbur. 1977. Two-step separation of human peripheral blood monocytes on discontinuous density gradients of colloidal silicapolyvinylpyrrolidinone. J. Immunol. Methods. 18:225-234.
12. 2+ mobilization, but not degranulation, in lyn-deficient bone marrow-derived mast cells. J. Immunol. 158:2350-2355.
13. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T. Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity. 3:549-560.
14. Yamanashi, Y., Y. Fukui, B. Wongsasant, Y. Kinoshita, Y. Ichimori, K. Toyoshima, and T. Yamamoto. 1992. Activation of Src-like protein-tyrosine kinase Lyn and its association with phosphatidylinositol 3-kinase upon B-cell antigen receptor-mediated signaling. Proc. Natl. Acad. Sci. USA. 89: 1118-1122.
15. Hibbs, M.L., D.M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S.A. Stacker, and A.R. Dunn. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell. 83:301-311.
16. Doody, G.M., P.W. Dempsey, and D.T. Fearon. 1996. Activation of B lymphocytes: integrating signals from CD19, CD22 and FcγRIIb1. Curr. Opin. Immunol. 8:378-382.
17. Ravetch, J.V. 1994. Fc receptors: rubor redux. Cell. 78: 553-560.
18. Takai, T., M. Ono, M. Hikida, H. Ohmori, and J.V. Ravetch. 1996. Augmented humoral and anaphylactic responses in Fc-γRII-deficient mice. Nature. 379:346-349.
19. D'Ambrosio, D., K.L. Hippen, S.A. Minskoff, I. Mellman, G. Pani, K.A. Siminovitch, and J.C. Cambier. 1995. Recruitment and activation of PTP1C in the negative regulation of antigen receptor signaling by FcγRIIB1. Science. 268:293-297.
20. Pani, G., M. Kozlowski, J.C. Cambier, G.B. Mills, and K.A. Siminovitch. 1995. Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. J. Exp. Med. 181: 2077-2084.
21. O'Keefe, T.L., G.T. Williams, S.L. Davies, and M.S. Neuberger. 1996. Hyperresponsive B cells in CD22-deficient mice. Science. 274:798-801.
22. Otipoby, K.L., K.B. Anderson, K.E. Draves, S.J. Klaus, A.G. Garr, J.D. Kerner, R.M. Perlmutter, C.-L. Law, and E.A. Clark. 1996. CD22 regulates thymus independent responses and the lifespan of B cells. Nature. 384:634-637.
23. Sato, S., A.S. Miller, M. Inaoki, C.B. Bock, P.J. Jansen, M.L. Tang, and T.F. Tedder. 1996. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity. 5:551-562.
24. Nitschke, L., R. Caresetti, B. Ocker, G. Kohler, and M.C. Lamers. 1997. CD22 is a negative regulator of B-cell receptor signaling. Curr. Biol. 7:133-143.
25. Muta, T., T. Kurosaki, Z. Misulovin, M. Sanchez, M.C. Nussenzweig, and J.V. Ravetch. 1994. A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signaling. Nature. 368:70-73.
26. Ono, M., S. Bolland, P. Tempst, and J.V. Ravetch. 1996. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. Nature. 383: 263-266.
27. Scharenberg, A.M., and J.P. Kinet. 1996. The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP? Cell. 87:961-964.
28. Ono, M., H. Okada, S. Bolland, S. Yanagi, T. Kurosaki, and J.V. Ravetch. 1997. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell. 90:293-301.
29. Schulte, R.J., M.A. Campbell, W.H. Fischer, and B.M. Sefton. 1992. Tyrosine phosphorylation of CD22 during B cell activation. Science. 258:1001-1004.
30. Campbell, M.A., and N.R. Klinman. 1995. Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C. Eur. J. Immunol. 25:1573-1579.
31. Doody, G.M., L.B. Justement, C.C. Delibrias, R.J. Matthews, J. Kin, M.L. Thomas, and D.T. Fearon. 1995. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science. 269:242-244.
32. Law, C.L., S.P. Sidorenko, K.A. Chandran, Z. Zhao, S.H. Shen, E.H. Fischer, and E.A. Clark. 1996. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-γ1 upon B cell activation. J. Exp. Med. 183:547-560.
33. Cyster, J.G., and C.C. Goodnow. 1997. Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment. Immunity. 6:509-517.
34. Daeron, M. 1997. Fc receptor biology. Annu. Rev. Immunol. 15:203-234.
35. Tedder, T.F., J. Tuscano, S. Sato, and J.H. Kehrl. 1997. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu. Rev. Immunol. 15:481-504.
36. Schmitz, R., G. Baumann, and H. Gram. 1996. Catalytic specificity of phosphotyrosine kinases Blk, Lyn, c-Src and Syk as assessed by phage display. J. Mol. Biol. 260:664-677.
37. Cambier, J.C. 1997. Inhibitory receptors abound? Proc. Natl. Acad. Sci. USA. 94:5993-5995.
38. Unkeless, J.C., and J. Jin. 1997. Inhibitory receptors, ITIM sequences and phosphatases. Curr. Opin. Immunol. 9:338-343.